Altasciences

Laval, Quebec, January 4, 2022 – Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept, announced today the completed acquisition of Sinclair Research, a preclinical CRO located in the Midwest. Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to Altasciences’ preclinical services across the U.S.

We provide proof of concept, R&D, clinical and commercial manufacturing, that includes liquid-filled capsules, band/sealing technologies, powder and over-encapsulated capsules, topical formulations, and clinical and blister packaging, manufactured in our purpose-built facility that includes state-of-the-art ISO 7 and ISO 8 cleanrooms.